Literature DB >> 8393268

Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction.

A Schwaiger1, F Umlauft, K Weyrer, C Larcher, J Lyons, V Mühlberger, O Dietze, K Grünewald.   

Abstract

Infection by enteroviruses, especially by Coxsackie B viruses, has been incriminated in pathogenesis of dilated cardiomyopathy. We developed polymerase chain reaction tests for the detection of enteroviral and Coxsackie B3 genomes, respectively, in myocardial biopsies obtained from a homogeneous group of 19 patients with idiopathic dilated cardiomyopathy. To determine unambiguously the incidence of enteroviruses and Coxsackie B3 viruses in these patients, we used two primer pairs, one common to all enteroviruses and the other specific for Coxsackie B3 viruses. In six patients of the dilated cardiomyopathy group, enteroviral ribonucleic acid (RNA) could be detected; only one was subspecified as Coxsackie B3 RNA. In contrast, no enteroviral RNA could be detected in a contrast group of 21 patients with other cardiac disorders. These results suggest that enteroviruses other than Coxsackie B3 are causally linked to the pathogenesis of dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393268     DOI: 10.1016/0002-8703(93)91058-m

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

2.  Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.

Authors:  H Zhang; P Morgan-Capner; N Latif; Y A Pandolfino; W Fan; M J Dunn; L C Archard
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization.

Authors:  P Halonen; E Rocha; J Hierholzer; B Holloway; T Hyypiä; P Hurskainen; M Pallansch
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

4.  Reverse transcription PCR to detect enteroviruses in surface water.

Authors:  M Gilgen; B Wegmüller; P Burkhalter; H P Bühler; U Müller; J Lüthy; U Candrian
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792

5.  Meta-analysis of the association of enteroviruses with human heart disease.

Authors:  C Baboonian; T Treasure
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

6.  Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy.

Authors:  P Muir; F Nicholson; S J Illavia; T S McNeil; J F Ajetunmobi; H Dunn; W G Starkey; K N Reetoo; N R Cary; J Parameshwar; J E Banatvala
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

7.  [MRI in chronic myocarditis].

Authors:  C T Kadalie
Journal:  Z Kardiol       Date:  2005
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.